A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity

Changrui Yang; Kaiyan Ye; Yizong Ding; Xingzhong Zhao; Yucheng T. Yang; Bowen Sun; Shuyi Qian; Mei‐Chun Cai; LuYan Liu; Libing Xiang; Xia Yin; Xing-Ming Zhao; Jieyi Wang; Jiwei Zhang; Wen Di; Guanglei Zhuang; Fan Yang; Changrui Yang; Kaiyan Ye; Yizong Ding; Xingzhong Zhao; Yucheng T. Yang; Bowen Sun; Shuyi Qian; Mei‐Chun Cai; LuYan Liu; Libing Xiang; Xia Yin; Xing-Ming Zhao; Jieyi Wang; Jiwei Zhang; Wen Di; Guanglei Zhuang; Fan Yang

doi:10.1038/s41551-025-01569-4

Keywords

Myeloid cellsAntibodyMyeloidImmunityImmune systemCytotoxicityCell cultureIn vitroHumoral immunity

Affiliated Institutions

Related Publications

T cells that help B cell responses to soluble antigen are distinguishable from those producing interleukin 2 on mitogenic or allogeneic stimulation.

Robert Arthur , Don Mason

An mAb MRC OX-22, reactive with the high molecular weight forms of the rat leukocyte-common antigen, has revealed a heterogeneity among CD4+ T cells in this species. Approximate...

1986 The Journal of Experimental Medicine 214 citations

<i>In Vitro</i> Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and <i>In Vivo</i> Toxicology in Non-Human Primates

Changyu Wang , Kent Thudium , Minhua Han +15 more

Abstract The programmed death-1 (PD-1) receptor serves as an immunologic checkpoint, limiting bystander tissue damage and preventing the development of autoimmunity during infla...

2014 Cancer Immunology Research 580 citations

Cancer Immunotherapy Comes of Age

Suzanne L. Topalian , George J. Weiner , Drew M. Pardoll

Cancer immunotherapy comprises a variety of treatment approaches, incorporating the tremendous specificity of the adaptive immune system (T cells and antibodies) as well as the ...

2011 Journal of Clinical Oncology 572 citations

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin , Xiuli Zhang , Heiko Schuster +24 more

The immune system influences the fate of developing cancers by not only functioning as a tumour promoter that facilitates cellular transformation, promotes tumour growth and scu...

2014 Nature 1936 citations

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

F. Stephen Hodi , Marcus O. Butler , Darryl A. Oble +17 more

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) functions as a negative regulator of endogenous and vaccine-induced antitumor immunity. The administration of fully human an...

2008 Proceedings of the National Academy o... 649 citations

Publication Info

Year: 2025
Type: article
Citations: 1
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Changrui Yang, 
                                
                                    Kaiyan Ye, 
                                
                                    Yizong Ding
                                
                                et al.
                            
                            (2025). 
                            A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity. 
                            Nature Biomedical Engineering
                            
                            .
                            https://doi.org/10.1038/s41551-025-01569-4

Identifiers

DOI: 10.1038/s41551-025-01569-4